Øystein Soug
Chief Executive Officer at Arxx Therapeutics AS
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Anders Fugelli | M | - |
Pharmasum Therapeutics AS
 Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | - |
| John Sigurd Mjøen Svendsen | M | 66 |
Pharmasum Therapeutics AS
Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | - |
| Diane Mellett | F | 64 | 9 years | |
| Robert Forbes Burns | M | 77 | 9 years | |
| Jonas Hallén | M | - |
Arxx Therapeutics AS
 Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | 5 years |
| Jörg Klingelhöfer | M | - |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | 6 years |
| Erik Digman Wiklund | M | - | 7 years | |
| Ola Melin | F | - | 3 years | |
| Lubor Gaal | M | 56 | 2 years | |
| Christian Schweiger | M | 57 |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | 4 years |
| Thomas Bieger | M | 63 |
University of St. Gallen
| 28 years |
| Kari Grønås | F | 59 |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | - |
| Susanne Stuffers | M | 43 |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | - |
| Yuri Khodjamirian | M | - |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | - |
| Birgitte Gangmark Villmo | F | - |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | - |
| Victor Levitsky | M | - | 4 years | |
| Damian Marron | M | 62 | 4 years | |
| Farzad Abdi-Dezfuli | M | - |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | - |
| Thomas Hansen | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jon Amund Eriksen | M | - | 6 years | |
| Catherine Wheeler | M | 71 | 3 years | |
| Martha Scheiber | M | 59 |
University of St. Gallen
| 3 years |
| Lars Lund-Roland | M | 68 | 2 years | |
| Eva-Lotta Allan | F | 65 | - | |
| Johan Rutger Christenson | M | 65 | 7 years | |
| Per Anders Göte Samuelsson | M | 63 | 7 years | |
| Lone Ottesen | M | - | - | |
| Gunnar Gårdemyr | M | 65 | 1 years | |
| Ulrich Sauter | M | 54 |
University of St. Gallen
| 5 years |
| Alexander Wolfang Ospelt | M | 57 |
University of St. Gallen
| 3 years |
| Bernhard Günther | M | 57 |
University of St. Gallen
| 2 years |
| Klaus Tschütscher | M | 57 |
University of St. Gallen
| 3 years |
| Anette Weber | F | 53 |
University of St. Gallen
| 5 years |
| Thomas Eisenring | M | 59 |
University of St. Gallen
| 3 years |
| Markus Naef | M | 55 |
University of St. Gallen
| 8 years |
| Dieter Dubs | M | 59 |
University of St. Gallen
| 3 years |
| Alexander Vögele | M | 63 |
University of St. Gallen
| 1 years |
| Othmar Karas | M | 66 |
University of St. Gallen
| 1 years |
| Sonia Quaratino | M | - | 2 years | |
| Anne-Kirsti Aksnes | F | - | - | |
| Tina Madsen | F | - | - | |
| Ursula Nötzli | M | - |
University of St. Gallen
| 2 years |
| Patrick Hauser | M | 55 |
University of St. Gallen
| 2 years |
| Christian Gärtner | M | 51 |
University of St. Gallen
| 4 years |
| Torbjørn Furuseth | M | - | 3 years | |
| Michael Bogenstaetter | M | - | - | |
| Matthias Bulach | M | 48 |
University of St. Gallen
| 5 years |
| Thomas Meier | M | 54 |
University of St. Gallen
| 2 years |
| Ingunn Munch Lindvig | M | - | - | |
| Jan Schoch | M | 47 |
University of St. Gallen
| 4 years |
| Axel P. Lehmann | M | 65 |
University of St. Gallen
| 3 years |
| Kurt Haerri | M | 62 |
University of St. Gallen
| 2 years |
| Rainer Hauser | M | 57 |
University of St. Gallen
| 2 years |
| Mauro Pedrazzini | M | 59 |
University of St. Gallen
| 2 years |
| Bruno Gehrig | M | 77 |
University of St. Gallen
| 4 years |
| Nicolas Fulpius | M | 51 |
University of St. Gallen
| 2 years |
| Marion Helmes | M | 58 |
University of St. Gallen
| 3 years |
| Marc Mogalle | M | 50 |
University of St. Gallen
| 4 years |
| Roman Kurmann | M | 55 |
University of St. Gallen
| 3 years |
| Dirk Lienemann | M | - |
University of St. Gallen
| 5 years |
| Florian Schweitzer | M | - |
University of St. Gallen
| 4 years |
| Patrick Volkert Vink | M | 60 | 3 years | |
| Jochen Kriegmeier | M | 54 |
University of St. Gallen
| 5 years |
| Hans-Friedrich Elmar Liebler | M | 55 |
University of St. Gallen
| 1 years |
| Ernst Chalupsky | M | 70 |
University of St. Gallen
| 1 years |
| Lukas Glanzmann | M | - |
University of St. Gallen
| 3 years |
| Sascha Gruber | M | - |
University of St. Gallen
| 5 years |
| Antti Vuolanto | M | - | 2 years | |
| Florian Ernst | M | 58 |
University of St. Gallen
| 3 years |
| Christoph Ganz | M | 54 |
University of St. Gallen
| 1 years |
| Ulrich Hermann | M | 57 |
University of St. Gallen
| 3 years |
| Rochus Kobler | M | 55 |
University of St. Gallen
| 3 years |
| Heinz Christoph Mäusli | M | 61 |
University of St. Gallen
| 1 years |
| Christian Katz | M | 57 |
University of St. Gallen
| 3 years |
| Monika Bütler | M | 63 |
University of St. Gallen
| 3 years |
| Meike Bütikofer | F | 63 |
University of St. Gallen
| 2 years |
| Carla Kriwet | M | 53 |
University of St. Gallen
| 3 years |
| Simon Kauth | M | 56 |
University of St. Gallen
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Switzerland | 44 | 56.41% |
| Norway | 34 | 43.59% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Øystein Soug
- Personal Network
